Analysts’ Viewpoint on Joint Pain Injections Market Scenario
The global joint pain injections market is expected to be driven by the rise in awareness about joint problems, significant unmet medical needs, and increase in geriatric population. New product development is, therefore, a major trend gaining traction in the global market. Key players in the joint pain injections market are focusing on developing innovative products to meet customer demand and increase their market share. For instance, injections of platelet-rich plasma and placental tissue matrix have proven to be effective in reducing the rate of infection, pain, and inflammation at the joint site. Rise in government expenditure on research & development for the production of affordable medications is creating value-grab opportunities for market players.
Injections for joint pain are usually administered directly into the joint to relieve pain and minimize swelling and discomfort. Joint discomfort is particularly common in the elderly population as a result of pre-existing illnesses or diseases. Musculoskeletal conditions such as arthritis and sacroiliac joint pain that cause pain and inflammation could contribute to joint discomfort. Rise in prevalence of osteoarthritis and rheumatoid arthritis; and increase in need for affordable treatments for such conditions are expected to increase the scope for joint pain injections market during the forecast period.
Joint pain due to arthritis is a prevalent complaint among people. It is also a significant contributor to reduced mobility and impairment. Currently, the available therapy options are insufficient, as they primarily concentrate on symptom alleviation and pain management. There are no medicines that can reverse or stop the progression of arthritis. Demand for new treatment options for joint pain is high, as people do not get relief from the already available medications. This is expected to drive the global joint pain injections market.
Arthritis is the most common cause of adult impairment globally. According to the Arthritis Foundation, osteoarthritis is the biggest cause of chronic impairment among the world's population. It ranks sixth among all forms of disability globally. Moreover, it is one of the most widespread musculoskeletal disorders, affecting 10% of the world's population aged over 60. In high-income countries, osteoarthritis affects up to 80% of those over 65, as it becomes more common with age. As the world's population ages, degenerative joint disease illnesses such as osteoarthritis are likely to affect at least 130 million people by 2031, according to projections by the Arthritis Foundation. This is likely to augment the global joint pain injections market in the next few years.
In terms of injection type, the global joint pain injections market has been divided into corticosteroid injections, hyaluronic acid injections, and others. The hyaluronic acid injections segment is projected to account for significant share of the global market during the forecast period. Large patient pool, preference for injections over surgeries, and approval of knee injections for the treatment of knee osteoarthritis are some of the factors that contribute to the increase in sale of hyaluronic acid injections. Furthermore, hyaluronic acid injections are quite effective in the treatment of knee osteoarthritis, while other treatments are contraindicated. This is likely to create lucrative opportunities for manufacturers to gain revenue benefits.
Based on joint type, the knee & ankle segment accounted for major share of the global market in 2021. The segment is expected to grow at a high CAGR during the forecast period. Rise in prevalence of knee & ankle injuries and increase in incidence of knee-related disorders such as osteoarthritis and rheumatoid arthritis across the globe are contributing to the segment's large market share. The prevalence of knee osteoarthritis has doubled in the U.S. since the mid-20th century, largely due to the increase in life expectancy.
In terms of distribution channel, the global joint pain injections market has been divided into hospital pharmacies, retail pharmacies, and online pharmacies. The hospitals pharmacies segment is projected to account for major share of the global market in 2021. This can be ascribed to the rise in number of hospital admissions due to the increase in preference for new treatment options such as viscosupplementation.
North America is projected to account for major share of the global joint pain injections market during the forecast period. This can be ascribed to the high acceptance of viscosupplementation with hyaluronic acid products along with significant number of people in the region being covered by medical insurance. Furthermore, viscosupplementation has been approved by the U.S. FDA for the treatment of knee osteoarthritis. The U.S. dominated the joint pain injections market in North America in 2021 due to the presence of a large patient pool, high acceptance of newer orthobiologic injections such as platelet-rich plasma, and increase in geriatric population in the country.
Europe was the second largest region of the global joint pain injections market in terms of share in 2021. This can be ascribed to the rise in prevalence of joint pain among the population, increase in incidence of osteoarthritis, high acceptance of new treatments, surge in geriatric population, and approval of innovative products by the European Union. Germany led the joint pain market in the region in 2021 owing to its large patient population. The usage of hyaluronic acid is expected to rise significantly in Germany due to the increase in demand for effective treatments for osteoarthritis.
The market in Asia Pacific is anticipated to grow at a high CAGR during the forecast period due to the presence of a large patient pool, increase in treatment penetration, surge in geriatric population, and rise in awareness about joint-related disorders in India and China.
The global joint pain injections market is highly fragmented, with a small number of large-scale vendors controlling majority of the share. Most companies are investing significantly in comprehensive research and development activities, primarily to create innovative products. Expansion of product portfolios and mergers & acquisitions are the prominent strategies adopted by key players. The global joint pain injections market report includes various sections such as joint pain injections market drivers, joint pain injections market analysis, and challenges and opportunities in the joint pain injections market. Allergan plc, Pfizer, Inc., Sanofi, Anika Therapeutics, Inc., Ferring B.V., Bioventus, Flexion Therapeutics, Inc., Zimmer Biomet Holdings, Inc., Seikagaku Corporation, and Chugai Pharmaceutical Co., Ltd. are the key players operating in the global join pain injections market.
Each of these players has been profiled in global joint pain injections market report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments.
|
Attribute |
Detail |
|
Market Size Value in 2021 |
US$ 4.7 Bn |
|
Market Forecast Value in 2031 |
More than US$ 9.8 Bn |
|
Growth Rate (CAGR) for 2022-2031 |
7.8% |
|
Forecast Period |
2022–2031 |
|
Historical Data Available for |
2017–2021 |
|
Quantitative Units |
US$ Bn for Value |
|
Market Analysis |
It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis. |
|
Competition Landscape |
|
|
Format |
Electronic (PDF) + Excel |
|
Market Segmentation |
|
|
Regions Covered |
|
|
Countries Covered |
|
|
Companies Profiled |
|
|
Customization Scope |
Available upon request |
|
Pricing |
Available upon request |
The global joint pain injections market was valued at US$ 4.7 Bn in 2021.
The global joint pain injections market is projected to reach more than US$ 9.8 Bn by 2031.
The global joint pain injections market grew at a CAGR of 7.2% from 2017 to 2021.
The global joint pain injections market is anticipated to grow a CAGR of 7.8% from 2022 to 2031.
The hyaluronic acid injections segment held major share of the global joint pain injections market in 2021.
North America is expected to account for major share of the global joint pain injections market during the forecast period.
Pfizer, Inc., Anika Therapeutics, Inc., Bioventus, Eli Lilly and Company, Ferring B.V., Pacira BioSciences, Inc. (Flexion Therapeutics), Sanofi, Seikagaku Corporation, and Zimmer Biomet.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Joint Pain Injections Market
4. Market Overview
4.1. Introduction
4.1.1. Segment Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Joint Pain Injections Market Analysis and Forecast, 2017–2031
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Technological Advancements
5.2. Regulatory Scenario by Region/globally
5.3. Pipeline Analysis
5.4. Disease Prevalence & Incidence Rate globally with key countries
5.5. Covid-19 Impact Analysis
6. Global Joint Pain Injections Market Analysis and Forecast, by Joint Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Joint Type, 2017–2031
6.3.1. Knee & Ankle
6.3.2. Hip Joint
6.3.3. Shoulder & Elbow
6.3.4. Facet Joints of Spine
6.3.5. Others
6.4. Market Attractiveness Analysis, by Joint Type
7. Global Joint Pain Injections Market Analysis and Forecast, by Injection Type
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Injection Type, 2017–2031
7.3.1. Corticosteroid Injections
7.3.2. Hyaluronic Acid Injections
7.3.3. Others
7.4. Market Attractiveness Analysis, by Injection Type
8. Global Joint Pain Injections Market Analysis and Forecast, by Distribution Channel
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by Distribution Channel, 2017–2031
8.3.1. Hospital Pharmacies
8.3.2. Online Pharmacies
8.3.3. Retail Pharmacies
8.4. Market Attractiveness Analysis, by Distribution Channel
9. Global Joint Pain Injections Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America Joint Pain Injections Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Joint Type, 2017–2031
10.2.1. Knee & Ankle
10.2.2. Hip Joint
10.2.3. Shoulder & Elbow
10.2.4. Facet Joints of Spine
10.2.5. Others
10.3. Market Value Forecast, by Injection Type, 2017–2031
10.3.1. Corticosteroid Injections
10.3.2. Hyaluronic Acid Injections
10.3.3. Others
10.4. Market Value Forecast, by Distribution Channel, 2017–2031
10.4.1. Hospital Pharmacies
10.4.2. Online Pharmacies
10.4.3. Retail Pharmacies
10.5. Market Value Forecast, by Country, 2017–2031
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Joint Type
10.6.2. By Injection Type
10.6.3. By Distribution Channel
10.6.4. By Country
11. Europe Joint Pain Injections Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Joint Type, 2017–2031
11.2.1. Knee & Ankle
11.2.2. Hip Joint
11.2.3. Shoulder & Elbow
11.2.4. Facet Joints of Spine
11.2.5. Others
11.3. Market Value Forecast, by Injection Type, 2017–2031
11.3.1. Corticosteroid Injections
11.3.2. Hyaluronic Acid Injections
11.3.3. Others
11.4. Market Value Forecast, by Distribution Channel, 2017–2031
11.4.1. Hospital Pharmacies
11.4.2. Online Pharmacies
11.4.3. Retail Pharmacies
11.5. Market Value Forecast, by Country/Sub-region, 2017–2031
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Italy
11.5.5. Spain
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Joint Type
11.6.2. By Injection Type
11.6.3. By Distribution Channel
11.6.4. By Country/Sub-region
12. Asia Pacific Joint Pain Injections Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Joint Type, 2017–2031
12.2.1. Knee & Ankle
12.2.2. Hip Joint
12.2.3. Shoulder & Elbow
12.2.4. Facet Joints of Spine
12.2.5. Others
12.3. Market Value Forecast, by Injection Type, 2017–2031
12.3.1. Corticosteroid Injections
12.3.2. Hyaluronic Acid Injections
12.3.3. Others
12.4. Market Value Forecast, by Distribution Channel, 2017–2031
12.4.1. Hospital Pharmacies
12.4.2. Online Pharmacies
12.4.3. Retail Pharmacies
12.5. Market Value Forecast, by Country/Sub-region, 2017–2031
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Joint Type
12.6.2. By Injection Type
12.6.3. By Distribution Channel
12.6.4. By Country/Sub-region
13. Latin America Joint Pain Injections Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Joint Type, 2017–2031
13.2.1. Knee & Ankle
13.2.2. Hip Joint
13.2.3. Shoulder & Elbow
13.2.4. Facet Joints of Spine
13.2.5. Others
13.3. Market Value Forecast, by Injection Type, 2017–2031
13.3.1. Corticosteroid Injections
13.3.2. Hyaluronic Acid Injections
13.3.3. Others
13.4. Market Value Forecast, by Distribution Channel, 2017–2031
13.4.1. Hospital Pharmacies
13.4.2. Online Pharmacies
13.4.3. Retail Pharmacies
13.5. Market Value Forecast, by Country/Sub-region, 2017–2031
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Joint Type
13.6.2. By Injection Type
13.6.3. By Distribution Channel
13.6.4. By Country/Sub-region
14. Middle East & Africa Joint Pain Injections Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Joint Type, 2017–2031
14.2.1. Knee & Ankle
14.2.2. Hip Joint
14.2.3. Shoulder & Elbow
14.2.4. Facet Joints of Spine
14.2.5. Others
14.3. Market Value Forecast, by Injection Type, 2017–2031
14.3.1. Corticosteroid Injections
14.3.2. Hyaluronic Acid Injections
14.3.3. Others
14.4. Market Value Forecast, by Distribution Channel, 2017–2031
14.4.1. Hospital Pharmacies
14.4.2. Online Pharmacies
14.4.3. Retail Pharmacies
14.5. Market Value Forecast, by Country/Sub-region, 2017–2031
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Joint Type
14.6.2. By Injection Type
14.6.3. By Distribution Channel
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player - Competition Matrix (by tier and size of companies)
15.2. Market Share Analysis, by Company, 2021
15.3. Company Profiles
15.3.1. Pfizer, Inc.
15.3.1.1. Company Overview
15.3.1.2. Financial Overview
15.3.1.3. Product Portfolio
15.3.1.4. Business Strategies
15.3.1.5. Recent Developments
15.3.2. Anika Therapeutics, Inc.
15.3.2.1. Company Overview
15.3.2.2. Financial Overview
15.3.2.3. Product Portfolio
15.3.2.4. Business Strategies
15.3.2.5. Recent Developments
15.3.3. Bioventus
15.3.3.1. Company Overview
15.3.3.2. Financial Overview
15.3.3.3. Product Portfolio
15.3.3.4. Business Strategies
15.3.3.5. Recent Developments
15.3.4. Eli Lilly and Company
15.3.4.1. Company Overview
15.3.4.2. Financial Overview
15.3.4.3. Product Portfolio
15.3.4.4. Business Strategies
15.3.4.5. Recent Developments
15.3.5. Ferring B.V.
15.3.5.1. Company Overview
15.3.5.2. Financial Overview
15.3.5.3. Product Portfolio
15.3.5.4. Business Strategies
15.3.5.5. Recent Developments
15.3.6. Pacira BioSciences, Inc. (Flexion Therapeutics)
15.3.6.1. Company Overview
15.3.6.2. Financial Overview
15.3.6.3. Product Portfolio
15.3.6.4. Business Strategies
15.3.6.5. Recent Developments
15.3.7. Sanofi
15.3.7.1. Company Overview
15.3.7.2. Financial Overview
15.3.7.3. Product Portfolio
15.3.7.4. Business Strategies
15.3.7.5. Recent Developments
15.3.8. Seikagaku Corporation
15.3.8.1. Company Overview
15.3.8.2. Financial Overview
15.3.8.3. Product Portfolio
15.3.8.4. Business Strategies
15.3.8.5. Recent Developments
15.3.9. Zimmer Biomet
15.3.9.1. Company Overview
15.3.9.2. Financial Overview
15.3.9.3. Product Portfolio
15.3.9.4. Business Strategies
15.3.9.5. Recent Developments
List of Tables
Table 01: Global Joint Pain Injection Market Value (US$ Mn) Forecast, by Joint Type, 2017–2031
Table 02: Global Joint Pain Injection Market Value (US$ Mn) Forecast, by Injection Type, 2017–2031
Table 03: Global Joint Pain Injection Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2031
Table 04: Global Joint Pain Injection Market Value (US$ Mn) Forecast, by Region , 2017–2031
Table 05: North America Joint Pain Injection Market Revenue (US$ Mn) Forecast, by Country, 2017–2031
Table 06: North America Joint Pain Injection Market Value (US$ Mn) Forecast, by Joint Type, 2017–2031
Table 07: North America Joint Pain Injection Market Value (US$ Mn) Forecast, by Injection Type, 2017–2031
Table 08: North America Joint Pain Injection Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2031
Table 09: Europe Joint Pain Injection Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 10: Europe Joint Pain Injection Market Value (US$ Mn) Forecast, by Joint Type, 2017–2031
Table 11: Europe Joint Pain Injection Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2031
Table 12: Asia Pacific Joint Pain Injection Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 13: Asia Pacific Joint Pain Injection Market Value (US$ Mn) Forecast, by Joint Type, 2017–2031
Table 14: Asia Pacific Joint Pain Injection Market Value (US$ Mn) Forecast, by Injection Type, 2017–2031
Table 15: Asia Pacific Joint Pain Injection Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2031
Table 16: Latin America Joint Pain Injection Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 17: Latin America Joint Pain Injection Market Value (US$ Mn) Forecast, by Joint Type, 2017–2031
Table 18: Latin America Joint Pain Injection Market Value (US$ Mn) Forecast, by Injection Type, 2017–2031
Table 19: Latin America Joint Pain Injection Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2031
Table 20: Middle East & Africa Joint Pain Injection Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 21: Middle East & Africa Joint Pain Injection Market Value (US$ Mn) Forecast, by Joint Type, 2017–2031
Table 22: Middle East & Africa Joint Pain Injection Market Value (US$ Mn) Forecast, by Injection Type, 2017–2031
Table 23: Middle East & Africa Joint Pain Injection Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2031
List of Figures
Figure 01: Global Joint Pain Injection Market Value (US$ Mn) Forecast, 2017–2031
Figure 02: Global Joint Pain Injection Market Value Share (%), by Joint Type, 2021
Figure 03: Global Joint Pain Injection Market Value Share (%), by Injection Type, 2021
Figure 04: Global Joint Pain Injection Market Value Share (%), by Distribution Channel, 2021
Figure 05: Global Joint Pain Injection Market Value Share (%), by Region, 2021
Figure 06: Global Joint Pain Injection Market Value Share (%), by Joint Type, 2017 and 2031
Figure 07: Global Joint Pain Injection Market Value Share (%), by Injection Type, 2017 and 2031
Figure 08: Global Joint Pain Injection Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Injection Type, 2017–2031
Figure 09: Global Joint Pain Injection Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Knee & Ankle 2017–2031
Figure 10: Global Joint Pain Injection Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hip Joint, 2017–2031
Figure 11: Global Joint Pain Injection Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Shoulder & Elbow, 2017–2031
Figure 12: Global Joint Pain Injection Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Facet Joints of Spine, 2017–2031
Figure 13: Global Joint Pain Injection Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2017–2031
Figure 14: Global Joint Pain Injection Market Attractiveness Analysis, by Joint Type, 2021–2031
Figure 15: Global Joint Pain Injection Market Attractiveness Analysis, by Injection Type, 2021–2031
Figure 16: Global Joint Pain Injection Market Attractiveness Analysis, by Devices, 2021–2031
Figure 17: Global Joint Pain Injection Market Value Share (%), by Distribution Channel, 2017 and 2031
Figure 18: Global Joint Pain Injection Market Attractiveness Analysis, by Distribution Channel, 2021–2031
Figure 19: Global Joint Pain Injection Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Corticosteroid Injections, 2017–2031
Figure 20: Global Joint Pain Injection Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hyaluronic Acid Injections, 2017–2031
Figure 21: Global Joint Pain Injection Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2017–2031
Figure 22: Global Joint Pain Injection Market Value Share (%), by Distribution Channel, 2017 and 2031
Figure 23: Global Joint Pain Injection Market Attractiveness Analysis, by Distribution Channel
Figure 24: Global Joint Pain Injection Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hospital Pharmacies, 2017–2031
Figure 25: Global Joint Pain Injection Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Retail Pharmacies, 2017–2031
Figure 26: Global Joint Pain Injection Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Online Pharmacies, 2017–2031
Figure 27: Global Joint Pain Injection Market Value Share Analysis, by Region, 2017 and 20231
Figure 28: Global Joint Pain Injection Market Attractiveness Analysis, by Region, 2021-2031
Figure 29: North America Joint Pain Injection Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
Figure 30: North America Joint Pain Injection Market Value Share (%), by Country, 2017 and 2031
Figure 31: North America Joint Pain Injection Market Attractiveness Analysis, by Country, 2022–2031
Figure 32: North America Joint Pain Injection Market Value Share, by Joint Type, 2017and 2031
Figure 33: North America Joint Pain Injection Market Attractiveness Analysis, by Joint Type, 2022–2031
Figure 34: North America Joint Pain Injection Market Value Share, by Distribution Channel, 2017 and 2031
Figure 35: North America Joint Pain Injection Market Attractiveness Analysis, by Distribution Channel, 2022–2031
Figure 36: Europe Joint Pain Injection Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
Figure 37: Europe Joint Pain Injection Market Value Share (%), by Country/Sub-region, 2017and 2031
Figure 38: Europe Joint Pain Injection Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
Figure 39: Europe Joint Pain Injection Market Value Share, by Joint Type, 2017 and 2031
Figure 40: Europe Joint Pain Injection Market Attractiveness Analysis, by Joint Type, 2022–2031
Figure 41: Europe Joint Pain Injection Market Value Share, by Distribution Channel, 2017 and 2031
Figure 42: Europe Joint Pain Injection Market Attractiveness Analysis, by Distribution Channel, 2022–2031
Figure 43: Asia Pacific Joint Pain Injection Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
Figure 44: Asia Pacific Joint Pain Injection Market Value Share (%), by Country/Sub-region, 2017 and 2031
Figure 45: Asia Pacific Joint Pain Injection Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
Figure 46: Asia Pacific Joint Pain Injection Market Value Share, by Joint Type, 2017 and 2031
Figure 47: Asia Pacific Joint Pain Injection Market Attractiveness Analysis, by Joint Type, 2022–2031
Figure 48: Asia Pacific Joint Pain Injection Market Value Share, by Distribution Channel, 2017 and 2031
Figure 49: Asia Pacific Joint Pain Injection Market Attractiveness Analysis, by Distribution Channel, 2022–2031
Figure 50: Latin America Joint Pain Injection Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
Figure 51: Latin America Joint Pain Injection Market Value Share (%), by Country/Sub-region, 2017 and 2031
Figure 52: Latin America Joint Pain Injection Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
Figure 53: Latin America Joint Pain Injection Market Value Share, by Joint Type, 2017 and 2031
Figure 54: Latin America Joint Pain Injection Market Attractiveness Analysis, by Joint Type, 2017–2031
Figure 55: Latin America Joint Pain Injection Market Value Share, by Distribution Channel, 2017 and 2031
Figure 56: Latin America Joint Pain Injection Market Attractiveness Analysis, by Distribution Channel, 2017–2031
Figure 57: Middle East & Africa Joint Pain Injection Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
Figure 58: Middle East & Africa Joint Pain Injection Market Value Share (%), by Country/Sub-region, 2017 and 2031
Figure 59: Middle East & Africa Joint Pain Injection Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
Figure 60: Middle East & Africa Joint Pain Injection Market Value Share, by Joint Type, 2017 and 2031
Figure 61: Middle East & Africa Joint Pain Injection Market Attractiveness Analysis, by Joint Type, 2022–2031
Figure 62: Middle East & Africa Joint Pain Injection Market Value Share, by Distribution Channel, 2017 and 2031
Figure 63: Middle East & Africa Joint Pain Injection Market Attractiveness Analysis, by Distribution Channel, 2022–2031
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Joint Pain Injections Market
